Design and synthesis of novel annulated thienopyrimidines as phosphodiesterase 5 (PDE5) inhibitors

被引：15
|
作者：
El-Sharkawy, Lina Y. [1 ]
El-Sakhawy, Rowaida A. [1 ]
Abdel-Halim, Mohammad [1 ]
Lee, Kevin [2 ]
Piazza, Gary A. [2 ]
Ducho, Christian [3 ]
Hartmann, Rolf W. [4 ]
Abadi, Ashraf H. [1 ]
机构：
[1] German Univ Cairo, Fac Pharm & Biotechnol, Dept Pharmaceut Chem, Cairo 11835, Egypt
[2] Univ S Alabama, Drug Discovery Res Ctr, Mitchell Canc Inst, Mobile, AL USA
[3] Saarland Univ, Dept Pharm Pharmaceut & Med Chem, Saarbrucken, Germany
[4] Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Drug Design & Optimizat, Saarbrucken, Germany
来源：
ARCHIV DER PHARMAZIE | 2018年 / 351卷 / 05期
关键词：
annulated thienopyrimidines; cycloalkene-fused thienopyrimidines; phosphodiesterase inhibitor; planarity; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; DRUG DEVELOPMENT; DERIVATIVES; DISCOVERY; AGENTS;
D O I：
10.1002/ardp.201800018
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Novel cycloalkene-fused thienopyrimidine analogues with enhanced phosphodiesterase 5 (PDE5) inhibitory properties are presented. The structure of the reported scaffold was modulated through variation of the terminal cycloalkene ring size, as well as by varying the substituents at position 4 through the attachment of different groups including aniline, benzylamine, cyclohexylethylamine, methyl/acetyl/aryl piperazines, and aryl hydrazones. Compound 15Y with a benzylamine substituent and cycloheptene as terminal ring showed the highest PDE5 inhibitory activity with an IC50 value as low as 190 nM and with good selectivity versus PDE7 and PDE9.
引用
收藏
页数：17
相关论文
共 50 条
  • [1] Natural phosphodiesterase 5 (PDE5) inhibitors: a computational approach
    Ongaro, Alberto
    Zagotto, Giuseppe
    Memo, Maurizio
    Gianoncelli, Alessandra
    Ribaudo, Giovanni
    NATURAL PRODUCT RESEARCH, 2021, 35 (10) : 1648 - 1653
  • [2] In silico design of novel hERG-neutral sildenafil-like PDE5 inhibitors
    Kayik, Gulru
    Tuzun, Nurcan S.
    Durdagi, Serdar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2017, 35 (13) : 2830 - 2852
  • [3] Phosphodiesterase 5 (PDE5): Structure-function regulation and therapeutic applications of inhibitors
    Ahmed, Wesam S.
    Geethakumari, Anupriya M.
    Biswas, Kabir H.
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 134
  • [4] PDE5 Inhibitors and their Applications
    Giovannoni, M. P.
    Vergelli, C.
    Graziano, A.
    Dal Piaz, V.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (24) : 2564 - 2587
  • [5] PDE5 inhibitors and male reproduction: Is there a place for PDE5 inhibitors in infertility clinics or andrology laboratories?
    Dimitriadis, Fotios
    Kaltsas, Aris
    Zachariou, Athanasios
    Mamoulakis, Charalampos
    Tsiampali, Chara
    Giannakis, Ioannis
    Paschopoulos, Minas
    Papatsoris, Athanasios
    Loutradis, Dimitrios
    Tsounapi, Panagiota
    Takenaka, Atsushi
    Sofikitis, Nikolaos
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (12) : 1405 - 1418
  • [6] High lung PDE5: A strong basis for treating pulmonary hypertension with PDE5 inhibitors
    Corbin, JD
    Beasley, A
    Blount, MA
    Francis, SH
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 334 (03) : 930 - 938
  • [7] Design, Synthesis and Structure-Activity Relationship of Functionalized Tetrahydro-β-carboline Derivatives as Novel PDE5 Inhibitors
    Ahmed, Nermin S.
    Gary, Bernard D.
    Tinsley, Hethar N.
    Piazza, Gary A.
    Laufer, Stefan
    Abadi, Ashraf H.
    ARCHIV DER PHARMAZIE, 2011, 344 (03) : 149 - 157
  • [8] Phosphodiesterase 5 (PDE5) inhibition, ANP and NO rapidly reduce epididymal duct contractions, but long-term PDE5 inhibition in vivo does not
    Mietens, Andrea
    Tasch, Sabine
    Feuerstacke, Caroline
    Eichner, Gerrit
    Volkmann, Johanna
    Schermuly, Ralph Theo
    Grimminger, Friedrich
    Mueller, Dieter
    Middendorff, Ralf
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 349 (02) : 145 - 153
  • [9] Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties
    Amin, Kamelia M.
    El-Badry, Ossama M.
    Rahman, Doaa E. Abdel
    Abdellattif, Magda H.
    Abourehab, Mohammed A. S.
    El-Maghrabey, Mahmoud H.
    Elsaid, Fahmy G.
    El Hamd, Mohamed A.
    Elkamhawy, Ahmed
    Ammar, Usama M.
    PHARMACEUTICS, 2022, 14 (09)
  • [10] Design, synthesis and biological evaluation of pyrazolopyrimidinone based potent and selective PDE5 inhibitors for treatment of erectile dysfunction
    Reddy, G. Lakshma
    Dar, Mohd Ishaq
    Hudwekar, Abhinandan D.
    Mahajan, Priya
    Nargotra, Amit
    Baba, Adil Manzoor
    Nandi, Utpal
    Wazir, Priya
    Singh, Gurdarshan
    Vishwakarma, Ram A.
    Syed, Sajad Hussain
    Sawant, Sanghapal D.
    BIOORGANIC CHEMISTRY, 2019, 89
12345